Forxiga
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Forxiga in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Forxiga.
21
Global Revenue Ranking
Recent articles on PMLiVE featuring Forxiga
An estimated 7.2 million people in the UK are living with the progressive condition
The chronic disease currently affects almost 30,000 people aged under 20 years in the US
The prevalence of type 2 diabetes in children and adolescents is increasing globally
More than 550,000 patients have a confirmed heart failure diagnosis in England alone
Chronic heart failure is the leading cause of hospitalisation for those over the age of 65
Chronic heart failure is the leading cause of hospitalisation for those over the age of 65
The recommendation is based on results from a phase 3 trial
Approval was based on positive data from the phase 3 trial for chronic kidney disease
Company is aiming for approval in prevention indication
Target action date set for January 2021
Drug reduced rate of cardiovascular deaths and hospitalisations
Formally rejects extended use of SGLT2 inhibitor
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology